ENvue Medical (FEED) Cash & Equivalents (2014 - 2026)

ENvue Medical (FEED) has 13 years of Cash & Equivalents data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 291.42% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 291.42% increase from a year earlier, with the FY2025 full-year figure at $4.2 million, up 461.7% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $2.2 million, down from $4.2 million in the prior quarter.
• Over the last five years, Cash & Equivalents for FEED reached as high as $7.0 million in Q3 2025 and fell as low as $253000.0 in Q2 2023.
• Historically, Cash & Equivalents has averaged $2.8 million across 5 years, with a median of $2.7 million in 2024.
• Across the five-year window, Cash & Equivalents plunged 93.59% in 2023 and jumped 757.71% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $2.7 million in 2022, then climbed by 21.01% to $3.3 million in 2023, then plunged by 77.09% to $752000.0 in 2024, then jumped by 461.7% to $4.2 million in 2025, then sank by 47.09% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $2.2 million in Q1 2026, $4.2 million in Q4 2025, and $7.0 million in Q3 2025.